Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q4 2025 Earnings Call Transcript February 25, 2026 Recursion Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.20528, expectations ...

Forbes contributors publish independent expert analyses and insights. Anjalee Khemlani is an award-winning business and health journalist. This voice experience is generated by AI. Learn more. This ...

Cash Balance: Ended the year with $754 million in cash. Operating Expenses: 35% reduction in pro forma operating expenses year over year. 2026 Cash Operating Expenses: Expected to be under $390 ...

In this Pharmaceutical Executive Academy discussion, Najat Khan, PhD, CEO of Recursion Pharmaceuticals and former chief data science officer at J&J, explores the intersection of AI, pharma, and ...

Recursion Pharmaceuticals’ latest earnings call struck a cautiously optimistic tone as management highlighted its first AI-enabled clinical proof-of-concept, major cost cuts, and an extended cash ...

By 2024, daily active wallet count across blockchain ecosystems crossed 7 million. Transaction hooks (code that intercepts, validates, or extends transaction logic in Web3) have become one of the most ...

About 100 jobs are to be created by call centre firm Clearanswer as it doubles the size of its Middlesbrough town centre base. The Hull-based firm opened up offices at Albert North last year, creating ...

When a worker thread completes a task, it doesn't return a sprawling transcript of every failed attempt; it returns a ...

GameSpot may get a commission from retail offers. Following the recent escalation of the United States and Israel's joint military campaign against Iran, the White House has taken to X to share a ...